1. TGF‐β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) Hospital Duran i Reynals Barcelona Spain
2. Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) ISCIII Instituto de Salud Carlos III Madrid Spain
3. Dermatology Service, IDIBELL Hospital Universitari de Bellvitge Barcelona Spain
4. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy University of Cologne Germany
5. Program Against Cancer Therapeutic Resistance (ProCURE) Catalan Institute of Oncology (ICO), Oncobell Program (IDIBELL) Barcelona Spain
6. Dermatology Department, Melanoma Unit, Hospital Clínic IDIBAPS & University of Barcelona Spain
7. Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER) ISCIII Instituto de Salud Carlos III Madrid Spain